# Your choices depend on the joint and the goal *Ways to Help Joint Soreness — Joint Injections Surprise* > Compare joint injections Surprise choices, including movement, cortisone, knee gel, PRP made from your blood and surgery alternatives. ## Keep the movement you can tolerate Choose activity that doesn't leave the joint much more sore the next day. Regular walking or strength work can still help if you later choose a shot. The likely cause and your health help narrow the choices. Cost, side effects, and how long relief may last also matter. ## Movement and simple care still matter Exercise helps keep the muscles around the joint working. If body weight adds strain, even a modest change may make movement easier. A brace made for the sore joint may reduce stress during the motion that hurts. Topical medicine means a cream or gel you put on the skin above that joint. Pills need more care if you have stomach, kidney, or heart concerns. These choices take time, but they don't prevent you from discussing a shot later. ## Cortisone acts sooner than knee gel Cortisone often acts sooner, though its relief usually fades with time. It may briefly raise blood sugar or make the joint more sore at first. A knee gel shot uses hyaluronic acid, a thick liquid meant to copy the slippery fluid in the joint. A doctor or another licensed health worker gives it through a needle. Gel tends to act more slowly, and its average benefit has been small in large studies. If surgery is planned, tell the surgeon which shot you had and when. ## PRP comes from a sample of your blood PRP stands for platelet-rich plasma. Clinic staff spin a blood sample and collect platelets into less liquid before the shot. Concentrated PRP contains more platelets in that smaller amount, though clinic methods differ. Studies don't give one clear answer for every joint or every PRP method. Alternatives to knee or hip surgery may be discussed when exercise and medicine haven't helped enough. Choose a date to test the daily task you want back, then ask about different care if it isn't easier. ## Sources 1. The 2015 Cochrane review of 27 trials (1,767 participants) found intra-articular corticosteroid better than sham for knee OA pain (SMD -0.40, 95% CI -0.58 to -0.22; NNTB 8), but the benefit decayed with time: moderate at 1-2 weeks, small at 13 weeks, and no evidence of any effect at 26 weeks. All outcomes were graded LOW quality. Jüni P, et al. — [Intra-articular corticosteroid for knee osteoarthritis.](https://pubmed.ncbi.nlm.nih.gov/26490760/). *Cochrane Database Syst Rev*, 2015. DOI: 10.1002/14651858.CD005328.pub3. 2. A 2022 BMJ systematic review and meta-analysis of 169 trials (21,163 participants) found viscosupplementation produced only a small pain reduction versus placebo (SMD -0.08, 95% CI -0.15 to -0.02; about -2.0 mm on a 100 mm VAS), below the minimal clinically important difference, and trial sequential analysis indicated conclusive evidence of clinical equivalence with placebo since 2009. Pereira TV, et al. — [Viscosupplementation for knee osteoarthritis: systematic review and meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/36333100/). *BMJ*, 2022. DOI: 10.1136/bmj-2022-069722. 3. A 2025 network meta-analysis restricted to LARGE randomized trials (57 RCTs, 22,795 participants, 18 intra-articular interventions) found treatment effects were larger in the 35 high-risk-of-bias trials than in the 22 low/unclear-risk trials; excluding high-risk trials, triamcinolone had the highest probability of exceeding the minimal important difference at weeks 2 and 6, while hyaluronic acid had no effect on pain (SMD -0.04, 95% CrI -0.19 to 0.11) and higher odds of dropouts due to adverse events (OR 2.01) and serious adverse events (OR 1.86) than placebo. Pereira TV, et al. — [Effectiveness and safety of intra-articular interventions for knee and hip osteoarthritis based on large randomized trials: A systematic review and network meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/39265924/). *Osteoarthritis Cartilage*, 2025. DOI: 10.1016/j.joca.2024.08.014. 4. The RESTORE randomized trial (288 participants, leukocyte-poor PRP, 3 weekly injections) found no significant difference from saline placebo at 12 months in knee pain (-2.1 vs -1.8 points; difference -0.4, 95% CI -0.9 to 0.2) or in medial tibial cartilage volume (-1.4% vs -1.2%), with 29 of 31 secondary outcomes also showing no between-group difference. Bennell KL, et al. — [Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial.](https://pubmed.ncbi.nlm.nih.gov/34812863/). *JAMA*, 2021. DOI: 10.1001/jama.2021.19415. 5. A 2024 network meta-analysis of 48 studies (9,338 knees) at minimum 6-month follow-up ranked PRP first for pain and function (SUCRA 91.5), then BMAC (76.5) and hyaluronic acid (53.1), with corticosteroid (15.2) barely above placebo (13.7) at that time point. Jawanda H, et al. — [Platelet-Rich Plasma, Bone Marrow Aspirate Concentrate, and Hyaluronic Acid Injections Outperform Corticosteroids in Pain and Function Scores at a Minimum of 6 Months as Intra-Articular Injections for Knee Osteoarthritis: A Systematic Review and Network Meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/38331363/). *Arthroscopy*, 2024. DOI: 10.1016/j.arthro.2024.01.037. 6. FDA's HCT/P guidance sets out the minimal-manipulation and homologous-use criteria that decide whether a human cell or tissue product is regulated solely under 21 CFR Part 1271 (section 361) or requires a biologics licence; cell-based orthopaedic injections that fall outside those criteria are unapproved drugs and biological products, and no cell-based product is FDA-approved to treat osteoarthritis. U.S. Food and Drug Administration — [Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use - Guidance for Industry and FDA Staff](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/regulatory-considerations-human-cells-tissues-and-cellular-and-tissue-based-products-minimal). *U.S. Food and Drug Administration*, 2020. ## A clinic visit can help you choose QC Kinetix in Peoria provides regenerative treatments, a term for non-surgical choices discussed with a licensed health worker after an exam and health review. Talk to the clinic team: --- Know why the joint is sore and what may help. Learn what can make one joint sore, what may soothe it at home, when medical care matters and where to find help in Surprise, Arizona. Clear answers about aching joints, care at home, urgent symptoms and a nearby clinic. This site is operated by the owners of the QC Kinetix Phoenix-area clinics, including the Peoria location identified for Surprise readers, and those owners benefit when a visitor books a consultation. © 2026 Surprise Joint Field Guide. General education only; this site does not diagnose a joint or replace care from a qualified clinician.